Evoq Remedies Profit & Loss Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs

4.78 +0.09 (1.92%)Updated : 16 Jun 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Revenue	11.76	4.05	20.39	16.78
Total Revenue	11.76	4.05	20.39	16.78
Costof Revenue Total	13.08	1.56	19.33	13.77
Gross Profit	-1.32	2.50	1.06	3.01
Selling/ General/ Admin Expenses Total	0.07	0.08	0.20	0.18
Depreciation/ Amortization	0.05	0.01	0.00	0.00
Other Operating Expenses Total	0.84	4.06	4.59	1.37
Total Operating Expense	14.04	5.70	24.13	15.32
Operating Income	-2.29	-1.65	-3.74	1.46
Interest Inc( Exp) Net- Non- Op Total	0.00	-	-	0.00
Other Net	2.41	2.26	6.02	0.00
Net Income Before Taxes	0.13	0.61	2.28	1.46
Provisionfor Income Taxes	0.04	0.16	0.67	0.37
Net Income After Taxes	0.09	0.45	1.62	1.09
Net Income Before Extra Items	0.09	0.45	1.62	1.09
Net Income	0.09	0.45	1.62	1.09
Income Availableto Com Excl Extra Ord	0.09	0.45	1.62	1.09
Income Availableto Com Incl Extra Ord	0.09	0.45	1.62	1.09
Diluted Net Income	0.09	0.45	1.62	1.09
Diluted Weighted Average Shares	2.21	1.36	1.36	1.36
Diluted EPS Excluding Extra Ord Items	0.04	0.33	1.19	0.80
Diluted Normalized EPS	0.04	0.33	1.19	0.80
period Length	12.00	12.00	12.00	12.00
period Type	-	-	-	-
Total Adjustmentsto Net Income	-	-	-	0.00
DPS- Common Stock Primary Issue	-	-	-	0.00